http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012527492-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D339-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D339-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D339-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-027
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D339-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
filingDate 2010-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2012527492-A
titleOfInvention Piperazine dithioctoate and pharmaceutical composition containing the same
abstract The present invention relates to piperazine dithioctoate, which is a novel basic addition salt of thioctic acid, and a pharmaceutical composition containing the same. The piperazine dithioctoate according to the present invention not only has excellent heat and moisture stability and solubility in aqueous solution, but also has a small increase in dosage associated with the production of addition salts, so that antioxidant or diabetic polyneuropathy It can be effectively used in a pharmaceutical composition for the prevention or treatment of the above.
priorityDate 2009-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08104629-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005502861-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9955331-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6112
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80509
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80510
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE7GMS1
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454613271
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546724
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3878934
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46833622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547291

Total number of triples: 45.